January 13, 2022 by Chain Drug Review
CVS Health, Mario Rivera, Michelle Peluso
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — Mario Rivera has joined CVS Health as senior vice president of Supply Chain, reporting to Michelle Peluso, executive vice president and chief customer officer, CVS Health and co-president, Retail. He will be responsible for their supply logistics, distribution, inventory, omnichannel and engineering, as CVS Health looks to transform its supply chain operations
January 13, 2022 by Bill Schiffner
Care Pharmacies, Mike Wysong
Featured Articles, January 10, 2022, Leading Headlines, Retail News
LINTHICUM, Md. — CARE Pharmacies is continuing to make its mark in the industry with new programs and initiatives to serve its growing membership that has seen its footprint rise to almost 130 pharmacies in 23 states. The Maryland-based company has added to its track record of growth by watching its sales expand to almost
January 12, 2022 by Geoff Walden
Julie Barber, Walmart
Featured Articles, January 10, 2022, Leading Headlines, Retail News
BENTONVILLE, Ark. — For Walmart’s Julie Barber, transitioning from food merchandising to a top position in the company’s health and wellness merchandising business, was “a perfect next step.” In the earlier role, she explains, she was already focused on health, because what people eat is so central to their well-being. “We were really leaning in
January 11, 2022 by Bill Schiffner
Rick Gates, Walgreens
Featured Articles, January 10, 2022, Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — Rick Gates developed a passion for retail pharmacy early on working at an independent drug store while still in high school. Today, as senior vice president of pharmacy and health care at Walgreens, he is making it possible for thousands of pharmacists to have an even greater impact on patient care. “The
January 10, 2022 by Jeffrey Woldt
Chain Drug Review's Video Forum, Colleen Lindholz, NACDS, Rick Keys, Steve Anderson is president and chief executive officer of the National Association of Chain Drug Stores.
Featured Articles, Leading Headlines, Videos
Chain Drug Review has named the National Association of Chain Drug Stores its Retailer of the Year. The designation might seem odd for an association, but NACDS is an organization comprised of retailers, with C-suite executives from member companies comprising the board of directors. This edition of Video Forum features three of NACDS’ key
January 7, 2022 by Chain Drug Review
Biden administration, DIR fees, NACDS
Featured Articles, Leading Headlines, Pharmacy
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) on Friday lauded the Biden Administration for initiating action to rein in direct and indirect remuneration (DIR) fees and pledged continued vigilance to optimize the regulatory proposal for the benefit of seniors and for the viability of the pharmacies that serve them. “DIR fees
January 6, 2022 by Chain Drug Review
Brewer, first quarter, Walgreens, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance far surpassed analysts’ expectations for first quarter profits, as adjusted earnings per share jumped 53.2% to $1.68. Wall Street’s consensus forecast for adjusted EPS was $1.33. With customers flocking to stores for COVID vaccines and tests, sales for the period ended November 30 climbed 7.8% from the year-ago quarter
January 5, 2022 by Chain Drug Review
Tom Ward, Walmart
Featured Articles, Leading Headlines, Retail News
BENTONVILLE, Ark. — Walmart is scaling up its InHome delivery service, with plans to make it available to 30 million households (up from 6 million today) by the end of the year. To that end, the company said Wednesday that it plans to hire more than 3,000 associate delivery drivers this year and will build
January 4, 2022 by Peter Matz
Pharmacy Outlook Peter Matz FMI – The Food Industry Association
Featured Articles, January 10, 2022, Leading Headlines, Opinion, Pharmacy
Throughout the COVID-19 public health emergency, the importance of pharmacies to the health and well-being of the American public has never been more clear. Following the development and approval of COVID-19 vaccines early last year, pharmacies played an integral role in administering millions of vaccine doses to the American people to combat the spread of
January 3, 2022 by John O'Brien
John O’Brien NPC
Featured Articles, January 10, 2022, Leading Headlines, Opinion, Pharmacy
As we head full steam into 2022, it is my hope that the new year brings about a much more informed public discussion about the important role prescription drugs play in our health care system and in improving the lives of patients. That would be a marked change from the past year, which prioritized rhetoric
December 31, 2021 by Scott Melville
Scott Melville President CEO Consumer Healthcare Products Association
Featured Articles, January 10, 2022, Leading Headlines, Opinion, Pharmacy
One of the most enduring outcomes of the global pandemic is the tremendous acceleration of self-care as a cornerstone of health care. Now, more than ever, consumers are taking greater responsibility for, and control over, their own health care. While it’s exciting to see broad industry growth, there’s no denying that consumer demand, and the
December 30, 2021 by Chip Davis
Chip Davis is the president and CEO of the Healthcare Distribution Alliance
Featured Articles, January 10, 2022, Leading Headlines, Opinion, Pharmacy
From the White House to the kitchen table, supply chain disruptions have been on the minds of many Americans. But while the COVID-19 pandemic revealed the limits of operating within a global marketplace, the pharmaceutical supply chain was largely immune to bottlenecks. Consumer goods shortages have challenged us recently, yet pharmacies, health systems and physicians’
December 29, 2021 by Dan Leonard
Dan Leonard is the president and CEO of Association for Accessible Medicines
Featured Articles, January 10, 2022, Leading Headlines, Opinion, Pharmacy
When patients receive their prescriptions at the pharmacy counter, the pharmacist is handing them a generic medicine nine times out of 10. Because of that, their co-pay is about 8.5 times more affordable than those for brands; 93% of the time generic co-pays are below $20. Doctors, pharmacists and patients count on the value proposition
December 28, 2021 by B. Douglas Hoey
B. Douglas Hoey is chief executive officer of the National Community Pharmacists Association.
Featured Articles, January 10, 2022, Leading Headlines, Opinion, Pharmacy
One positive result of the coronavirus pandemic is that it has forever changed the consumer’s view of pharmacy. Of course, the evolving perception of the role of the pharmacist was already very much in progress. But the pandemic propelled it forward in ways that will have some radical effects on the business model of community